LOAMU
ONCE

Lombard Odier Asset Management (USA)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$1.02M – 331
2019
Q2 		$1.02M Sell
10,000
-5,000
-33% -$540K 0.08% 168
2019
Q1 		$1.71M Buy
+15,000
New +$1.1M 0.14% 148

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s ONCE Position: Q3 2019 in Review

Lombard Odier Asset Management (USA) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 10,000 shares — an estimated $1.02M sold.

Lombard Odier Asset Management (USA) first reported a position in ONCE in Q1 2019 and held it in 2 quarters. The position peaked at $1.71M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Lombard Odier Asset Management (USA) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 10,000 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $1.02M.
  • Lombard Odier Asset Management (USA) first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s Spark Therapeutics, Inc. Common Stock position peaked at $1.71M in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2019, filed 14 Nov 2019.